merged_africa-snakebite-treatment-access.txt
<question_number>1</question_number>
<answer>Hemotoxic venom causing blood‑clotting disruption and tissue necrosis leading to gangrene</answer>
<question_number>2</question_number>
<answer>Indian antivenom is formulated for Indian snake toxins and lacks antibodies against Kenyan puff‑adder venom, whose composition differs regionally</answer>
<question_number>3</question_number>
<answer>Neurotoxic (cobra/mamba) and hemotoxic (puff‑adder) toxin families; current antivenoms are species‑specific and cannot neutralize both, prompting monoclonal development</answer>
<question_number>4</question_number>
<answer>Spitting cobra venom in the eye mimics a simple ocular injury, and patients first seek traditional healers who may not recognize venom, leading to misdiagnosis</answer>
<question_number>5</question_number>
<answer>Rainy‑season flooding forces snakes into homes, dry‑season food‑search drives them onto farms; combined with barefoot field work and sleeping on floors, this spikes bites among farmers and children at those times</answer>
<question_number>6</question_number>
<answer>1) Front‑fanged, short erect fangs delivering venom deep quickly; 2) extremely potent neurotoxic venom that acts within minutes; 3) rapid, agile striking behavior/large body allowing swift envenomation</answer>
<question_number>7</question_number>
<answer>Antivenom requires refrigeration and must be given within six hours, but Kenya’s cold‑chain gaps and typical >7‑hour delays mean pregnant victims often miss timely treatment, worsening maternal/fetal outcomes</answer>
<question_number>8</question_number>
<answer>Tourniquets cut off circulation, causing tissue death and amputations, and combined with delayed hospital care they worsen outcomes rather than protect the victim</answer>